Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance
Go back to Benchmark Reiterates Hold Rating on Neogenomics (NEO) on 2025 Revenue Guidance| NEOGENOMICS (NASDAQ: NEO) | Delayed: 16.63 +0.06 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.57 | 52 Week High | $9.54 | |||
| Open | $16.53 | 52 Week Low | $5.49 | |||
| Day High | $16.92 | P/E | 415.75 | |||
| Day Low | $16.33 | EPS | $0.04 | |||
| Volume | 1,945,747 | |||||

